| Secondary |
| Product Used For Unknown Indication |
51.0% |
| Drug Abuse |
11.5% |
| Pain |
7.0% |
| Abdominal Pain |
3.7% |
| Depressed Mood |
3.3% |
| Depression |
3.3% |
| Back Pain |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Neuralgia |
2.1% |
| Anxiety |
1.6% |
| Metastases To Spine |
1.6% |
| Spinal Pain |
1.6% |
| Analgesic Therapy |
1.2% |
| Hypertension |
1.2% |
| Muscle Spasms |
1.2% |
| Pain Management |
1.2% |
| Drug Use For Unknown Indication |
0.8% |
| Migraine |
0.8% |
| Prostate Cancer |
0.8% |
| Substance Use |
0.8% |
|
| Substance Abuse |
15.4% |
| Drug Abuse |
10.3% |
| Dyspnoea |
10.3% |
| Drug Dependence |
7.7% |
| Drug Withdrawal Syndrome |
5.1% |
| Intentional Drug Misuse |
5.1% |
| Nausea |
5.1% |
| Pain |
5.1% |
| Serotonin Syndrome |
5.1% |
| Vestibular Disorder |
5.1% |
| Blood Testosterone Decreased |
2.6% |
| Diarrhoea |
2.6% |
| Dizziness |
2.6% |
| Drug Ineffective |
2.6% |
| Exposure During Pregnancy |
2.6% |
| Intestinal Obstruction |
2.6% |
| Lethargy |
2.6% |
| Multiple Sclerosis Relapse |
2.6% |
| Nervousness |
2.6% |
| Overdose |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
55.1% |
| Pain |
11.9% |
| Premedication |
4.5% |
| Back Pain |
4.1% |
| Breakthrough Pain |
3.7% |
| Rheumatoid Arthritis |
2.3% |
| Hypertension |
2.2% |
| Hepatitis C |
2.1% |
| Supplementation Therapy |
2.0% |
| Depression |
1.8% |
| Analgesic Therapy |
1.4% |
| Gout |
1.1% |
| Osteoporosis |
1.1% |
| Anxiety |
1.1% |
| Neck Pain |
1.1% |
| Psoriatic Arthropathy |
1.1% |
| Diabetes Mellitus |
0.9% |
| Osteoporosis Postmenopausal |
0.9% |
| Prostate Cancer |
0.9% |
| Blood Pressure |
0.8% |
|
| Inadequate Analgesia |
14.2% |
| Drug Ineffective |
11.0% |
| Vomiting |
9.7% |
| Pain |
9.0% |
| Product Quality Issue |
5.2% |
| Therapeutic Response Decreased |
5.2% |
| Death |
4.5% |
| Headache |
4.5% |
| Nausea |
4.5% |
| Injection Site Pain |
3.9% |
| Paraesthesia |
3.9% |
| Rash |
3.9% |
| Weight Decreased |
3.9% |
| Pruritus |
3.2% |
| Irritability |
2.6% |
| Pain In Extremity |
2.6% |
| Weight Increased |
2.6% |
| Dyspnoea |
1.9% |
| Inappropriate Schedule Of Drug Administration |
1.9% |
| Infusion Related Reaction |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
95.2% |
| Renal Transplant |
4.8% |
|
| Treatment Noncompliance |
100.0% |
|
